D. Jeffrey Demanes

Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer

Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography–Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer

Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features

Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer

Clinical Outcomes for Patients with Gleason Score 9–10 Prostate Adenocarcinoma Treated With Radiotherapy or Radical Prostatectomy: A Multi-institutional Comparative Analysis

High-dose-rate brachytherapy monotherapy without androgen deprivation therapy for intermediate-risk prostate cancer

High-Dose-Rate Monotherapy for Localized Prostate Cancer: 10-Year Results

Long-Term (10-15 Year) Results With High-Dose-Rate-(HDR) Salvage Therapy for Recurrent Prostate Cancer

High-dose-rate brachytherapy as monotherapy for prostate cancer

American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: High-dose-rate brachytherapy

American Brachytherapy Society consensus guidelines for high-dose-rate prostate brachytherapy

American Brachytherapy Society consensus guidelines for adjuvant vaginal cuff brachytherapy after hysterectomy

American Brachytherapy Society consensus guidelines for interstitial brachytherapy for vaginal cancer

Intraoperative Ultrasonography-Guided Positioning of Iodine 125 Plaque Brachytherapy in the Treatment of Choroidal Melanoma